Lifelong exogenous insulin administration is the standard treatment for T1DM; however, it is difficult to maintain physiological insulin levels, and therefore, this treatment is not very effective in alleviating T1DM complications such as retinopathy, nephropathy, and neuropathy [4]. The gene discussed is INS; the disease is Nephropathy.